Unum Group 6.250% Junior Subordinated Notes due 2058 news

Zacks Rank #3 (Hold) with strong operational excellence, encouraging sales trends, favorable risk results, and impressive dividend track record with 10-15% future increases. 2026-2027 earnings expected to grow 6.3% and 9.1% respectively.

Unum delivered a significant revenue surprise of +14.98% versus consensus estimates and beat EPS expectations. Most operational metrics performed in line with or better than analyst estimates, including strong premium income growth of +4.2% year-over-year and net investment income growth of +9.6%. However, the modest overall revenue growth of 0.7% year-over-year and the Hold rating temper the enthusiasm.

While Unum beat earnings and revenue estimates with a +0.92% surprise and outperformed the S&P 500 year-to-date (+17.4% vs +10.2%), the Zacks Rank #3 (Hold) rating reflects mixed estimate revisions and the weak industry outlook (bottom 30% of industries), suggesting near-term performance in line with the market.

Expected earnings growth of 4.3% YoY with positive Earnings ESP (+0.64%) and Zacks Rank #3 prediction of earnings beat. U.S. segment benefits from higher premiums and sales growth, though offset by revenue decline and international headwinds.

Unum demonstrates a consistent history of beating earnings estimates with an average surprise of 2.16% over the past two quarters. The company has a positive Earnings ESP of +0.64%, indicating recent analyst bullishness on earnings prospects. Combined with its Zacks Rank #3, this suggests a high probability (~70%) of another earnings beat in the upcoming November 3, 2026 report.

Company expects 8-12% EPS growth in 2026, maintains strong dividend track record with 19 increases in 17 years, plans $1 billion in buybacks, and benefits from disciplined pricing and high persistency. However, sentiment is tempered by rising claims costs and declining investment income.

Colonial Life segment showed strong fundamentals with 11.9% operating income growth, 6% sales growth, favorable claims experience, 17.6% jump in investment income, and 19.4% ROE. However, sentiment is tempered by slight persistency decline and modest premium growth. Stock carries Zacks Rank #4 (Sell) despite 18.6% YTD gains.

While Q2 earnings beat estimates and the stock gained 9.4%, the company faces significant operational headwinds including a 22.8% decline in Unum U.S. adjusted operating income, 41.6% decline in International segment income, and deteriorating disability experience. Post-earnings estimate revisions have trended downward, and the Zacks Rank #4 (Sell) rating indicates below-average expected returns despite near-term stock appreciation.

Company raised dividend nearly 10% and returned ~$280 million through dividends and buybacks in Q3, showing commitment to shareholder returns. However, this was offset by a net loss driven largely by investment losses, resulting in a mixed financial picture.

Solid operational excellence, strong persistency, favorable risk results, and impressive dividend track record with 17 increases in 16 years. 2026-2027 earnings expected to grow 6.3% and 9.1% respectively, with long-term growth rate of 11.9%.

Adjusted operating earnings of $2.20 beat consensus by only 0.9%, but bottom line declined 21.7% YoY. Adjusted operating income declined significantly, with group disability down 60.4% and Unum International down 99.5% YoY.

Mixed results with earnings beat offset by 21.7% YoY decline, strong premium growth and investment income countered by elevated disability claims and significant international business deterioration (99.5% operating income decline). Colonial Life strength provides some positive offset.

Expected to report earnings of $2.18 per share, representing +4.3% year-over-year growth. Consensus EPS estimate revised 0.1% higher over last 30 days. However, revenues expected to decline 12.5% year-over-year to $2.96 billion. Mixed signals with earnings growth offset by revenue decline.

Expected year-over-year EPS growth of 4.3%. Positive Earnings ESP of +0.64% combined with Zacks Rank #3 indicates likely earnings beat. Company surpassed consensus estimates in 2 of last 4 quarters, showing more consistent performance than Aflac.

Expected to be driven by higher premiums, improved persistency, and solid sales across business segments. Favorable claims experience in group life and supplemental insurance, plus higher investment yields, support profitability. Zacks Rank #3 with 4.3% earnings growth expected, though elevated disability claims and Closed Block losses present risks.

Unum Group is mentioned only as a competitor through its Colonial Life unit without any specific performance data or analysis provided in the article.

Unum Group is mentioned only as a tokenized asset now available for trading. The announcement provides no information about the company's operations or performance, making sentiment assessment neutral.

Expected 8%-12% EPS growth and 4%-7% core operations growth for 2026; sustained profitability with nearly two decades of consistent dividend increases; 2.49% dividend yield; approximately 30% upside potential; benefits from market dislocation despite being fundamentally disconnected from Iran conflict

Unum is mentioned as a customer relying on Ushur's platform, but the article provides no specific information about Unum's implementation or outcomes.